MRNA

Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
vaccines
MRNA
Merck
Asia-Pacific
Flag link:
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Fierce Biotech
Moderna Therapeutics
MRNA
intracellular proteins
clinical trials
propionic acidemia
Flag link:
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
PR Newswire
Myeloid Therapeutics
funding
MRNA
immunotherapy
Flag link:
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Drugs.com
universal flu vaccine
clinical trials
NIAID
MRNA
vaccines
Flag link:
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Fierce Pharma
Moderna Therapeutics
Alnylam
MRNA
vaccines
legals
Flag link:
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Flag link:
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
GSK
CureVac
vaccines
MRNA
Flu
Flag link:
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
BioSpace
Moderna Therapeutics
Merck
MRNA
cancer vaccines
vaccines
Flag link:
Where Will Moderna Be in 1 Year?
Where Will Moderna Be in 1 Year?
Motley Fool
Moderna Therapeutics
MRNA
vaccines
COVID-19
RSV
CMV
Flag link:
FDA amends COVID vaccine EUAs, considers animal studies to accelerate updates
FDA amends COVID vaccine EUAs, considers animal studies to accelerate updates
RAPS.org
FDA
regulatory
COVID-19
vaccines
MRNA
Flag link:
‘Welcome to the mRNAge’: Moderna launches global mRNA campaign
‘Welcome to the mRNAge’: Moderna launches global mRNA campaign
Medical Marketing and Media
Moderna Therapeutics
MRNA
vaccines
Flag link:
Moderna announces new vaccine candidates against Lyme disease and norovirus
Moderna announces new vaccine candidates against Lyme disease and norovirus
Biopharma Reporter
Moderna Therapeutics
MRNA
vaccines
Lyme disease
norovirus
Flag link:
Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine
Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine
Investors Business Daily
Moderna Therapeutics
Merck
MRNA
cancer
vaccines
Europe
cancer vaccine
Flag link:
Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant
Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant
Endpoints
Pfizer
BioNTech
patents
COVID-19
vaccines
Arbutus
MRNA
Flag link:
Q&A: Newly-minted CSL chief executive Paul McKenzie and chief medical officer Bill Mezzanotte
Q&A: Newly-minted CSL chief executive Paul McKenzie and chief medical officer Bill Mezzanotte
Endpoints
CSL
MRNA
Pharma CEOs
Paul McKenzie
Flag link:
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
BioSpace
Moderna Therapeutics
MRNA
vaccines
cancer
cancer vaccines
Flag link:
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Medical Marketing and Media
Moderna Therapeutics
MRNA
UK
drug manufacturing
Flag link:
Spotlight – Cystic fibrosis developers take a deep breath
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
Flag link:
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Investors Business Daily
Moderna Therapeutics
earnings
MRNA
vaccines
FDA
cancer vaccines
Flag link:
mRNA offers new hope to Strep A vaccine development
mRNA offers new hope to Strep A vaccine development
Biopharma Reporter
MRNA
vaccines
strep A
funding
Flag link:

Pages